Duloxetine - low dose: Clinical Trials

3 trials of Duloxetine - low dose, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 1 Not applicable, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable1Completed 1
Phase 11Completed 1
Phase 41Completed 1

Follow Duloxetine - low dose: new trials by email Literature Review of Duloxetine - low dose trials Research Report on Duloxetine - low dose

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Frequency Rhythmic Electrical Modulated Stimulation Effect in Peripheral Neuropathy Patients Severity of Cases and Qol.
frequency rhythmic electrical modulated stimulation., Duloxetine - low dose - Peripheral Neuropathy With Type 2 Diabetes
Not applicableCompletedBeni-Suef University342026-07-122026-11-10
Duloxetine As an Analgesic in Patients Without Central Sensitivity After Same Sitting Bilateral Total Knee Arthroplasty
Duloxetine - low dose, Placebo - Osteoarthritis of Knee, Central Sensitization
Phase 4CompletedOrthopaedic Arthroscopy Knee and Shoulder Clinic1062021-01-012025-02-20
Tolerability and Safety of Duloxetine BID in Healthy Female Subjects
Duloxetine - low dose, Duloxetine - high dose, Placebo - Healthy
Phase 1CompletedBoehringer Ingelheim322003-06-012014-09-05

Conditions studied

Bronchiolitis Obliterans Syndrome (1)  ·  Osteoarthritis, Knee (1)  ·  Pain (1)

Sponsors

Beni-Suef University (1)  ·  Boehringer Ingelheim (1)  ·  Orthopaedic Arthroscopy Knee and Shoulder Clinic (1)

Countries

Egypt (1)  ·  India (1)